| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $130K | -99.8% |
| R&D Expense | $182.9M | +14.9% |
| SG&A Expense | $67.0M | -42.9% |
| Operating Income | -$247.0M | -32.0% |
| Net Income | -$234.6M | -28.1% |
| EPS (Basic) | -$0.93 | -25.7% |
| EPS (Diluted) | -$0.93 | -25.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $145.6M | +17.9% |
| Short-term Investments | $400.6M | -22.5% |
| Current Assets | $554.7M | -14.8% |
| Total Assets | $750.0M | -20.0% |
| Current Liabilities | $34.5M | -6.8% |
| Total Liabilities | $95.1M | -8.9% |
| Stockholders' Equity | $655.0M | -21.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$163.7M | +3.5% |
| Capital Expenditures | $2.7M | -88.9% |
| Investing Cash Flow | $184.0M | +1694.9% |
| Financing Cash Flow | $1.7M | -83.6% |
| Free Cash Flow | -$166.4M | +14.2% |